ArticleViruses2025
Antenatal Screening for HTLV-1 and -2 Among Pregnant Women in Grenada: Combined Seroprevalence, Trends, and Public Health Implications (2015-2024).
Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of Human T-cell Lymphotropic Virus (HTLV) infections in Grenada has not been published since 2013. This study aimed to determine the combined seroprevalence and trends in HTLV-1 and HTLV-2 among pregnant women in Grenada from 2015 to 2024. Data were analyzed to determine the overall combined seroprevalence, observed trends, and public health implications over time. Data obtained from the Ministry of Health, Grenada, were analyzed to determine and compare the annual combined seroprevalence rate and the prevalence by age group and by health district during 2015-2024. Every pregnant woman included in the analysis was tested for HTLV-1 and -2 at the government's public laboratories in Grenada. The overall rate of infection among persons tested was 1.45%. The highest prevalence of infection was among the 40+ (mature) age group. A significant association was found between HTLV infection and the mature age group (ϰ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.